Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates (original) (raw)

Abstract

BACKGROUND: In spite of the large number of studies that have evaluated DNA-based immunization, few have directly compared the immune responses generated by different routes of immunization, particularly in non-human primates. Here we examine the ability of a hepatitis B surface antigen (HBsAg)-encoding plasmid to induce immune responses in mice and non-human primates (rhesus monkeys: Macaca mulatta) after delivery by a number of routes. MATERIALS AND METHODS: Eight different injected [intraperitoneal (IP), intradermal (ID), intravenous (IV), intramuscular (IM), intraperineal (IPER), subcutaneous (SC), sublingual (SL), vaginal wall (VW)] and six noninjected [intranasal inhalation (INH), intranasal instillation (INS), intrarectal (IR), intravaginal (IVAG), ocular (Oc), oral feeding (oral)] routes and the gene gun (GG) were used to deliver HBsAg-expressing plasmid DNA to BALB/c mice. Sera were assessed for HBsAg-specific antibodies (anti-HBs, IgG, IgG1, IgG2a) and cytotoxic T lymphocyte (CTL) activity measured. Three of the most commonly used routes (IM, ID, GG) were compared in rhesus monkeys, also using HBsAg-expressing vectors. Monkeys were immunized with short (0-, 4- and 8-week) or long (0-, 12- and 24-week) intervals between boosts, and in the case of GG, also with different doses, and their sera were assessed for anti-HBs. RESULTS: In one study, anti-HBs were detected in plasma of mice treated by five of eight of the injected and none of the six noninjected routes. The highest levels of anti-HBs were induced by IM and IV injections, although significant titers were also obtained with SL and ID. Each of these routes also induced CTL, as did IPER and VW and one noninjected route (INH) that failed to induce antibodies. In a second study, GG (1.6 microg) was compared to ID and IM (100 microg) delivery. Significant titers were obtained by all routes after only one boost, with the highest levels detected by IM. Delivery to the skin by GG induced exclusively IgG1 antibodies (Th2-like) at 4 weeks and only very low IgG2a levels at later times; ID-immunized mice had predominantly IgG1 at 4 weeks and this changed to mixed IgG1/IgG2a over time. Responses with IM injection (in the leg or tongue) were predominantly IgG2a (Th1-like) at all times. IV injection gave mixed IgG1/IgG2a responses. In monkeys, in the first experiment, 1 mg DNA IM or ID at 0, 4, and 8 weeks gave equivalent anti-HB titers and 0.4 microg at the same times by GG induced lower titers. In the second experiment, 1 mg DNA IM or ID, or 3.2 microg by GG, at 0, 12, and 24 weeks, gave anti-HB values in the hierarchy of GG > IM > ID. Furthermore, high titers were retained after a single immunization in mice but fell off over time in the monkeys, even after boost. CONCLUSIONS: Route of administration of plasmid DNA vaccines influences the strength and nature of immune responses in mice and non-human primates. However, the results in mice were not always predictive of those in monkeys and this is likely true for humans as well. Optimal dose and immunization schedule will most likely vary between species. It is not clear whether results in non-human primates will be predictive of results in humans, thus additional studies are required. http://link.springer-ny.com/link/service/journals/00020/bibs /5n5p287. html

287

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bagarazzi M. L., Boyer J. D., Javadian M. A., Chattergoon M., Dang K., Kim G., Shah J., Wang B., Weiner D. B. Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees. J Med Primatol. 1997 Feb-Apr;26(1-2):27–33. doi: 10.1111/j.1600-0684.1997.tb00316.x. [DOI] [PubMed] [Google Scholar]
  2. Barry M. A., Johnston S. A. Biological features of genetic immunization. Vaccine. 1997 Jun;15(8):788–791. doi: 10.1016/s0264-410x(96)00265-4. [DOI] [PubMed] [Google Scholar]
  3. Blessing T., Remy J. S., Behr J. P. Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1427–1431. doi: 10.1073/pnas.95.4.1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boyer J. D., Ugen K. E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M. L., Chattergoon M., Frost P., Javadian A., Williams W. V. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med. 1997 May;3(5):526–532. doi: 10.1038/nm0597-526. [DOI] [PubMed] [Google Scholar]
  5. Boyer J. D., Wang B., Ugen K. E., Agadjanyan M., Javadian A., Frost P., Dang K., Carrano R. A., Ciccarelli R., Coney L. In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol. 1996 Jun;25(3):242–250. doi: 10.1111/j.1600-0684.1996.tb00022.x. [DOI] [PubMed] [Google Scholar]
  6. Boyle J. S., Koniaras C., Lew A. M. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol. 1997 Dec;9(12):1897–1906. doi: 10.1093/intimm/9.12.1897. [DOI] [PubMed] [Google Scholar]
  7. Brazolot Millan C. L., Weeratna R., Krieg A. M., Siegrist C. A., Davis H. L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15553–15558. doi: 10.1073/pnas.95.26.15553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Calarota S., Bratt G., Nordlund S., Hinkula J., Leandersson A. C., Sandström E., Wahren B. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet. 1998 May 2;351(9112):1320–1325. doi: 10.1016/S0140-6736(97)09440-3. [DOI] [PubMed] [Google Scholar]
  9. Cardoso A. I., Blixenkrone-Moller M., Fayolle J., Liu M., Buckland R., Wild T. F. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. Virology. 1996 Nov 15;225(2):293–299. doi: 10.1006/viro.1996.0603. [DOI] [PubMed] [Google Scholar]
  10. Casares S., Inaba K., Brumeanu T. D., Steinman R. M., Bona C. A. Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med. 1997 Nov 3;186(9):1481–1486. doi: 10.1084/jem.186.9.1481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chattergoon M. A., Robinson T. M., Boyer J. D., Weiner D. B. Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages/antigen-presenting cells. J Immunol. 1998 Jun 15;160(12):5707–5718. [PubMed] [Google Scholar]
  12. Chen S. C., Jones D. H., Fynan E. F., Farrar G. H., Clegg J. C., Greenberg H. B., Herrmann J. E. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol. 1998 Jul;72(7):5757–5761. doi: 10.1128/jvi.72.7.5757-5761.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chu R. S., Targoni O. S., Krieg A. M., Lehmann P. V., Harding C. V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med. 1997 Nov 17;186(10):1623–1631. doi: 10.1084/jem.186.10.1623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Condon C., Watkins S. C., Celluzzi C. M., Thompson K., Falo L. D., Jr DNA-based immunization by in vivo transfection of dendritic cells. Nat Med. 1996 Oct;2(10):1122–1128. doi: 10.1038/nm1096-1122. [DOI] [PubMed] [Google Scholar]
  15. Corr M., Lee D. J., Carson D. A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med. 1996 Oct 1;184(4):1555–1560. doi: 10.1084/jem.184.4.1555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Daheshia M., Kuklin N., Manickan E., Chun S., Rouse B. T. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccine. 1998 Jul;16(11-12):1103–1110. doi: 10.1016/s0264-410x(98)80105-9. [DOI] [PubMed] [Google Scholar]
  17. Davis H. L., Mancini M., Michel M. L., Whalen R. G. DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost. Vaccine. 1996 Jun;14(9):910–915. doi: 10.1016/0264-410x(95)00255-y. [DOI] [PubMed] [Google Scholar]
  18. Davis H. L., McCluskie M. J., Gerin J. L., Purcell R. H. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7213–7218. doi: 10.1073/pnas.93.14.7213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Davis H. L., Michel M. L., Mancini M., Schleef M., Whalen R. G. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine. 1994 Dec;12(16):1503–1509. doi: 10.1016/0264-410x(94)90073-6. [DOI] [PubMed] [Google Scholar]
  20. Davis H. L., Michel M. L., Whalen R. G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet. 1993 Nov;2(11):1847–1851. doi: 10.1093/hmg/2.11.1847. [DOI] [PubMed] [Google Scholar]
  21. Davis H. L., Millan C. L., Watkins S. C. Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther. 1997 Mar;4(3):181–188. doi: 10.1038/sj.gt.3300380. [DOI] [PubMed] [Google Scholar]
  22. Davis H. L., Schleef M., Moritz P., Mancini M., Schorr J., Whalen R. G. Comparison of plasmid DNA preparation methods for direct gene transfer and genetic immunization. Biotechniques. 1996 Jul;21(1):92-4, 96-9. doi: 10.2144/96211st03. [DOI] [PubMed] [Google Scholar]
  23. Davis H. L., Weeratna R., Waldschmidt T. J., Tygrett L., Schorr J., Krieg A. M., Weeranta R. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol. 1998 Jan 15;160(2):870–876. [PubMed] [Google Scholar]
  24. Davis H. L., Whalen R. G., Demeneix B. A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum Gene Ther. 1993 Apr;4(2):151–159. doi: 10.1089/hum.1993.4.2-151. [DOI] [PubMed] [Google Scholar]
  25. Doe B., Selby M., Barnett S., Baenziger J., Walker C. M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8578–8583. doi: 10.1073/pnas.93.16.8578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Donnelly J. J., Ulmer J. B., Shiver J. W., Liu M. A. DNA vaccines. Annu Rev Immunol. 1997;15:617–648. doi: 10.1146/annurev.immunol.15.1.617. [DOI] [PubMed] [Google Scholar]
  27. Etchart N., Buckland R., Liu M. A., Wild T. F., Kaiserlian D. Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin. J Gen Virol. 1997 Jul;78(Pt 7):1577–1580. doi: 10.1099/0022-1317-78-7-1577. [DOI] [PubMed] [Google Scholar]
  28. Feltquate D. M., Heaney S., Webster R. G., Robinson H. L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol. 1997 Mar 1;158(5):2278–2284. [PubMed] [Google Scholar]
  29. Fuller D. H., Corb M. M., Barnett S., Steimer K., Haynes J. R. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine. 1997 Jun;15(8):924–926. doi: 10.1016/s0264-410x(96)00271-x. [DOI] [PubMed] [Google Scholar]
  30. Fuller D. H., Haynes J. R. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1433–1441. doi: 10.1089/aid.1994.10.1433. [DOI] [PubMed] [Google Scholar]
  31. Fuller D. H., Murphey-Corb M., Clements J., Barnett S., Haynes J. R. Induction of immunodeficiency virus-specific immune responses in rhesus monkeys following gene gun-mediated DNA vaccination. J Med Primatol. 1996 Jun;25(3):236–241. doi: 10.1111/j.1600-0684.1996.tb00021.x. [DOI] [PubMed] [Google Scholar]
  32. Fynan E. F., Webster R. G., Fuller D. H., Haynes J. R., Santoro J. C., Robinson H. L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11478–11482. doi: 10.1073/pnas.90.24.11478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Geissler M., Gesien A., Tokushige K., Wands J. R. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol. 1997 Feb 1;158(3):1231–1237. [PubMed] [Google Scholar]
  34. Gramzinski R. A., Millan C. L., Obaldia N., Hoffman S. L., Davis H. L. Immune response to a hepatitis B DNA vaccine in Aotus monkeys: a comparison of vaccine formulation, route, and method of administration. Mol Med. 1998 Feb;4(2):109–118. [PMC free article] [PubMed] [Google Scholar]
  35. Gregoriadis G., Saffie R., de Souza J. B. Liposome-mediated DNA vaccination. FEBS Lett. 1997 Feb 3;402(2-3):107–110. doi: 10.1016/s0014-5793(96)01507-4. [DOI] [PubMed] [Google Scholar]
  36. Haynes J. R., McCabe D. E., Swain W. F., Widera G., Fuller J. T. Particle-mediated nucleic acid immunization. J Biotechnol. 1996 Jan 26;44(1-3):37–42. doi: 10.1016/0168-1656(96)80298-7. [DOI] [PubMed] [Google Scholar]
  37. Hinkula J., Lundholm P., Wahren B. Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses. Vaccine. 1997 Jun;15(8):874–878. doi: 10.1016/s0264-410x(96)00257-5. [DOI] [PubMed] [Google Scholar]
  38. Ishii N., Fukushima J., Kaneko T., Okada E., Tani K., Tanaka S. I., Hamajima K., Xin K. Q., Kawamoto S., Koff W. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses. 1997 Nov 1;13(16):1421–1428. doi: 10.1089/aid.1997.13.1421. [DOI] [PubMed] [Google Scholar]
  39. Iwasaki A., Stiernholm B. J., Chan A. K., Berinstein N. L., Barber B. H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol. 1997 May 15;158(10):4591–4601. [PubMed] [Google Scholar]
  40. Iwasaki A., Torres C. A., Ohashi P. S., Robinson H. L., Barber B. H. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol. 1997 Jul 1;159(1):11–14. [PubMed] [Google Scholar]
  41. Jones D. H., Corris S., McDonald S., Clegg J. C., Farrar G. H. Poly(DL-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine. 1997 Jun;15(8):814–817. doi: 10.1016/s0264-410x(96)00266-6. [DOI] [PubMed] [Google Scholar]
  42. Keller E. T., Burkholder J. K., Shi F., Pugh T. D., McCabe D., Malter J. S., MacEwen E. G., Yang N. S., Ershler W. B. In vivo particle-mediated cytokine gene transfer into canine oral mucosa and epidermis. Cancer Gene Ther. 1996 May-Jun;3(3):186–191. [PubMed] [Google Scholar]
  43. Kim J. J., Ayyavoo V., Bagarazzi M. L., Chattergoon M. A., Dang K., Wang B., Boyer J. D., Weiner D. B. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J Immunol. 1997 Jan 15;158(2):816–826. [PubMed] [Google Scholar]
  44. Kim J. J., Trivedi N. N., Nottingham L. K., Morrison L., Tsai A., Hu Y., Mahalingam S., Dang K., Ahn L., Doyle N. K. Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol. 1998 Mar;28(3):1089–1103. doi: 10.1002/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
  45. Klinman D. M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol. 1997 Apr 15;158(8):3635–3639. [PubMed] [Google Scholar]
  46. Krieg A. M., Wu T., Weeratna R., Efler S. M., Love-Homan L., Yang L., Yi A. K., Short D., Davis H. L. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12631–12636. doi: 10.1073/pnas.95.21.12631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Krieg A. M., Yi A. K., Matson S., Waldschmidt T. J., Bishop G. A., Teasdale R., Koretzky G. A., Klinman D. M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 1995 Apr 6;374(6522):546–549. doi: 10.1038/374546a0. [DOI] [PubMed] [Google Scholar]
  48. Kuklin N., Daheshia M., Karem K., Manickan E., Rouse B. T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J Virol. 1997 Apr;71(4):3138–3145. doi: 10.1128/jvi.71.4.3138-3145.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Le Borgne S., Mancini M., Le Grand R., Schleef M., Dormont D., Tiollais P., Rivière Y., Michel M. L. In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen. Virology. 1998 Jan 20;240(2):304–315. doi: 10.1006/viro.1997.8942. [DOI] [PubMed] [Google Scholar]
  50. Leclerc C., Dériaud E., Rojas M., Whalen R. G. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA. Cell Immunol. 1997 Aug 1;179(2):97–106. doi: 10.1006/cimm.1997.1161. [DOI] [PubMed] [Google Scholar]
  51. Liu Y., Mounkes L. C., Liggitt H. D., Brown C. S., Solodin I., Heath T. D., Debs R. J. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotechnol. 1997 Feb;15(2):167–173. doi: 10.1038/nbt0297-167. [DOI] [PubMed] [Google Scholar]
  52. Livingston J. B., Lu S., Robinson H., Anderson D. J. Immunization of the female genital tract with a DNA-based vaccine. Infect Immun. 1998 Jan;66(1):322–329. doi: 10.1128/iai.66.1.322-329.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. MacGregor R. R., Boyer J. D., Ugen K. E., Lacy K. E., Gluckman S. J., Bagarazzi M. L., Chattergoon M. A., Baine Y., Higgins T. J., Ciccarelli R. B. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis. 1998 Jul;178(1):92–100. doi: 10.1086/515613. [DOI] [PubMed] [Google Scholar]
  54. Macklin M. D., McCabe D., McGregor M. W., Neumann V., Meyer T., Callan R., Hinshaw V. S., Swain W. F. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J Virol. 1998 Feb;72(2):1491–1496. doi: 10.1128/jvi.72.2.1491-1496.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Manickan E., Rouse R. J., Yu Z., Wire W. S., Rouse B. T. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol. 1995 Jul 1;155(1):259–265. [PubMed] [Google Scholar]
  56. Mathiowitz E., Jacob J. S., Jong Y. S., Carino G. P., Chickering D. E., Chaturvedi P., Santos C. A., Vijayaraghavan K., Montgomery S., Bassett M. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 1997 Mar 27;386(6623):410–414. doi: 10.1038/386410a0. [DOI] [PubMed] [Google Scholar]
  57. McCluskie M. J., Davis H. L. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol. 1998 Nov 1;161(9):4463–4466. [PubMed] [Google Scholar]
  58. Michel M. L., Davis H. L., Schleef M., Mancini M., Tiollais P., Whalen R. G. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5307–5311. doi: 10.1073/pnas.92.12.5307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Mor G., Klinman D. M., Shapiro S., Hagiwara E., Sedegah M., Norman J. A., Hoffman S. L., Steinberg A. D. Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol. 1995 Aug 15;155(4):2039–2046. [PubMed] [Google Scholar]
  60. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J., Wahren B., Okuda K. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J Immunol. 1997 Oct 1;159(7):3638–3647. [PubMed] [Google Scholar]
  61. Pertmer T. M., Roberts T. R., Haynes J. R. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol. 1996 Sep;70(9):6119–6125. doi: 10.1128/jvi.70.9.6119-6125.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Prayaga S. K., Ford M. J., Haynes J. R. Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization. Vaccine. 1997 Aug-Sep;15(12-13):1349–1352. doi: 10.1016/s0264-410x(97)00036-4. [DOI] [PubMed] [Google Scholar]
  63. Prince A. M., Whalen R., Brotman B. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus. Vaccine. 1997 Jun;15(8):916–919. doi: 10.1016/s0264-410x(96)00248-4. [DOI] [PubMed] [Google Scholar]
  64. Raz E., Carson D. A., Parker S. E., Parr T. B., Abai A. M., Aichinger G., Gromkowski S. H., Singh M., Lew D., Yankauckas M. A. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9519–9523. doi: 10.1073/pnas.91.20.9519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Richmond J. F., Lu S., Santoro J. C., Weng J., Hu S. L., Montefiori D. C., Robinson H. L. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting. J Virol. 1998 Nov;72(11):9092–9100. doi: 10.1128/jvi.72.11.9092-9100.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Robinson H. L., Boyle C. A., Feltquate D. M., Morin M. J., Santoro J. C., Webster R. G. DNA immunization for influenza virus: studies using hemagglutinin- and nucleoprotein-expressing DNAs. J Infect Dis. 1997 Aug;176 (Suppl 1):S50–S55. doi: 10.1086/514176. [DOI] [PubMed] [Google Scholar]
  67. Robinson H. L., Torres C. A. DNA vaccines. Semin Immunol. 1997 Oct;9(5):271–283. doi: 10.1006/smim.1997.0083. [DOI] [PubMed] [Google Scholar]
  68. Sasaki S., Hamajima K., Fukushima J., Ihata A., Ishii N., Gorai I., Hirahara F., Mohri H., Okuda K. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine. Infect Immun. 1998 Feb;66(2):823–826. doi: 10.1128/iai.66.2.823-826.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Sato Y., Roman M., Tighe H., Lee D., Corr M., Nguyen M. D., Silverman G. J., Lotz M., Carson D. A., Raz E. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science. 1996 Jul 19;273(5273):352–354. doi: 10.1126/science.273.5273.352. [DOI] [PubMed] [Google Scholar]
  70. Schneider J., Gilbert S. C., Blanchard T. J., Hanke T., Robson K. J., Hannan C. M., Becker M., Sinden R., Smith G. L., Hill A. V. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med. 1998 Apr;4(4):397–402. doi: 10.1038/nm0498-397. [DOI] [PubMed] [Google Scholar]
  71. Tang D. C., DeVit M., Johnston S. A. Genetic immunization is a simple method for eliciting an immune response. Nature. 1992 Mar 12;356(6365):152–154. doi: 10.1038/356152a0. [DOI] [PubMed] [Google Scholar]
  72. Torres C. A., Iwasaki A., Barber B. H., Robinson H. L. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol. 1997 May 15;158(10):4529–4532. [PubMed] [Google Scholar]
  73. Ugen K. E., Boyer J. D., Wang B., Bagarazzi M., Javadian A., Frost P., Merva M. M., Agadjanyan M. G., Nyland S., Williams W. V. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial. Vaccine. 1997 Jun;15(8):927–930. doi: 10.1016/s0264-410x(96)00254-x. [DOI] [PubMed] [Google Scholar]
  74. Ugen K. E., Nyland S. B., Boyer J. D., Vidal C., Lera L., Rasheid S., Chattergoon M., Bagarazzi M. L., Ciccarelli R., Higgins T. DNA vaccination with HIV-1 expressing constructs elicits immune responses in humans. Vaccine. 1998 Nov;16(19):1818–1821. doi: 10.1016/s0264-410x(98)00180-7. [DOI] [PubMed] [Google Scholar]
  75. Ulmer J. B., Deck R. R., Dewitt C. M., Donnhly J. I., Liu M. A. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology. 1996 Sep;89(1):59–67. doi: 10.1046/j.1365-2567.1996.d01-718.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Wang B., Dang K., Agadjanyan M. G., Srikantan V., Li F., Ugen K. E., Boyer J., Merva M., Williams W. V., Weiner D. B. Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine. 1997 Jun;15(8):821–825. doi: 10.1016/s0264-410x(96)00259-9. [DOI] [PubMed] [Google Scholar]
  77. Wang R., Doolan D. L., Charoenvit Y., Hedstrom R. C., Gardner M. J., Hobart P., Tine J., Sedegah M., Fallarme V., Sacci J. B., Jr Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect Immun. 1998 Sep;66(9):4193–4202. doi: 10.1128/iai.66.9.4193-4202.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Wang R., Doolan D. L., Le T. P., Hedstrom R. C., Coonan K. M., Charoenvit Y., Jones T. R., Hobart P., Margalith M., Ng J. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science. 1998 Oct 16;282(5388):476–480. doi: 10.1126/science.282.5388.476. [DOI] [PubMed] [Google Scholar]
  79. Wolff J. A., Ludtke J. J., Acsadi G., Williams P., Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet. 1992 Sep;1(6):363–369. doi: 10.1093/hmg/1.6.363. [DOI] [PubMed] [Google Scholar]
  80. Wolff J. A., Malone R. W., Williams P., Chong W., Acsadi G., Jani A., Felgner P. L. Direct gene transfer into mouse muscle in vivo. Science. 1990 Mar 23;247(4949 Pt 1):1465–1468. doi: 10.1126/science.1690918. [DOI] [PubMed] [Google Scholar]
  81. Yokoyama M., Zhang J., Whitton J. L. DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity. FEMS Immunol Med Microbiol. 1996 Jul;14(4):221–230. doi: 10.1111/j.1574-695X.1996.tb00290.x. [DOI] [PubMed] [Google Scholar]